SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIAs board investigation into reports that CEO Jensen Huangs relationship involved a suspected Chinese intelligence asset is dominating discussion, with traders weighing national-security and governance risks and uncertainty about his leadership against claims the story is overblown and the AI business remains intact. The community is split between buying the selloff and worrying about possible damage to customer trust or increased scrutiny of chip sales to China.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Q3 results drew attention after revenue missed expectations and declined from the prior quarter, prompting concerns about commercial execution, BCG supply and potential dilution. Traders are weighing that setback against ANKTIVAs positive BCG-naive trial result and expanded approvals, with debate focused on whether upcoming data and broader access can support future sales.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Q3 results beat expectations and management raised its full-year revenue outlook on continued BRIUMVI growth, prompting mostly bullish reactions. Traders are also focused on the upcoming subcutaneous BRIUMVI Phase 3 readout, though some caution that strong results may already be priced in.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,200,877.25744775. The last known price of Ethereum is 2,141.49627095 USD and is down -4.09 over the last 24 hours. It is currently trading on 14297 active market(s) with $9,084,277,576.13 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is drawing attention amid a sharp crypto-market selloff, with traders citing broader risk-off pressure and leveraged liquidations; some speculate that tech-market weakness and regulatory concerns are adding to the pressure. The community is split between bearish calls for further losses and dip buyers who view the decline as an accumulation opportunity.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedixs agreement to acquire substantially all of Heron Therapeutics assets, including four commercial products, is driving attention. Traders are split on whether the deal broadens the companys revenue base efficiently or weighs on CRMD through the cash-and-stock consideration and acquisition risk.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Attention is centered on upcoming quarterly earnings, with traders split between fears of another weak report or outlook after a steep decline and hopes for a recovery-driven beat and short covering. Some bulls also see co-founder Dave Pickles return to an expanded technology leadership role as a positive, though its impact remains uncertain.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

A strong Q3 earnings beat and raised full-year outlook are driving attention, with traders linking Constellations growth prospects to demand for nuclear power from AI data centers. The reaction is largely bullish, though some traders question why the shares have not risen more and debate valuation and capital spending.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab in hidradenitis suppurativa and the coming FDA review-timeline decision are driving discussion, alongside Mercks competing HS data. Traders debate whether sonelokimabs clinical results can sustain a competitive edge and whether MoonLake can commercialize alone, with some expecting a catalyst-driven rebound and others concerned about competition, approval risk, and dilution.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutixs Q3 update and AXPAXLIs planned Q4 NDA filing are driving attention, with traders focused on whether SOL-R safety data and the companys cash runway support the regulatory and launch timeline. Some see the cash position and filing progress as reassuring, while others remain frustrated that the NDA has not been submitted and question the timeline and commercial prospects.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is under pressure amid a broader crypto selloff, with traders also pointing to political uncertainty and stalled expectations around crypto legislation as possible headwinds. The discussion is sharply divided between holders buying the dip and bearish traders anticipating further declines toward or below $1.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
